The Sonic Healthcare Board of Directors is comprised of individuals experienced in public company management and stewardship. As a group, they bring to the company a broad skill base encompassing medical, financial, legal, management and corporate areas. In view of the fact that Sonic Healthcare specialises in providing medical diagnostic services, the Board is committed to ensuring that its membership includes pathologists and radiologists.

The current Board of Directors consists of four independent directors (including the Chairman) and three executive directors, including a pathologist and a radiologist.


Mark Compton  

Professor Mark Compton 
AM., B.Sc., M.B.A., F.A.I.C.D., F.A.I.M., A.F.C.H.S.M.
Non-executive, independent Director, appointed October 2014 (Chairman from 19 November 2015)

Prof. Compton has extensive senior executive experience in healthcare services. He is currently Adjunct Professor in Management (Healthcare Leadership) at Macquarie Graduate School of Management, non-executive director of Macquarie University Hospital and Macquarie University Clinical Associates Ltd, Chairman and Chancellor of St John Ambulance Australia (having served as a volunteer for 38 years) and Chief Executive Officer of St Luke's Care. His previous experience includes Chief Executive Officer of Immune Systems Therapeutics Limited, National Chief Executive Officer of The Royal Flying Doctor Service of Australia, and Chief Executive Officer and Managing Director of the formerly ASX listed companies SciGen Limited and Alpha Healthcare Limited. He has also held a number of non-executive director roles including for formerly ASX-listed Independent Practitioner Network Limited (2004 to 2008), and as Chairman of The Woolcock Institute of Medical Research. In recognition of his work in the healthcare sector and his service to the community, he was awarded the Centenary Medal of the Commonwealth of Australia, appointed a Knight in the Order of St John in 2004 and was appointed as a Member of the Order of Australia (AM) in January 2010. He is a member of the Audit Committee and the Remuneration and Nomination Committee.


Dr Colin Goldschmidt
CEO and Managing Director
M.B.B.Ch., F.R.C.P.A., F.A.I.C.D.
Executive Director, appointed January 1993

Dr Goldschmidt is the CEO and Managing Director of Sonic Healthcare. He is a qualified medical doctor who then undertook specialist pathology training in Sydney, before gaining his Specialist Pathologist qualification in 1986. Dr Goldschmidt practised for five years (1987-1992) as a histopathologist with Douglass Hanly Moir Pathology, Sonic’s first acquisition, prior to his appointment as CEO of both Sonic Healthcare and Douglass Hanly Moir Pathology in 1993. He is a member of numerous medical and pathology associations and a member of Sonic’s Risk Management Committee. 


Christopher Wilks
CFO and Finance Director
B.Comm. (Univ Melb), F.A.I.C.D.
Executive director, appointed December 1989

Mr Wilks has a background in chartered accounting and investment banking. He was previously a partner in a private investment bank and has held directorships for a number of public companies. He is currently a director of Silex Systems Limited (since 1988).


Dr Philip Dubois
M.B., B.S., F.R.C.R., F.R.A.N.Z.C.R., F.A.I.C.D.
Executive Director, appointed July 2001

Dr Dubois is CEO of Sonic Imaging, Chairman of the Sonic Imaging Executive Committee and is Chairman and CEO of Queensland X-Ray. A neuroradiologist and nuclear imaging specialist, he is currently an Associate Professor of Radiology at the University of Queensland Medical School. He has served on numerous government and craft group bodies, including the councils of the Royal Australian and New Zealand College of Radiologists and the Australian Medical Association, and as Vice-President of the Australian Diagnostic Imaging Association. Dr Dubois is a non-executive director of Magnetica Limited (since December 2004).


Lou Panaccio
B.Ec., C.A., M.A.I.C.D.
Non-executive, independent Director, appointed June 2005

Mr Panaccio is a chartered accountant with strong management experience in business and healthcare services. He is currently on the boards of ASX listed companies Genera Biosystems Limited (Executive Chairman from July 2011, Director from November 2010) and Avita Medical Limited (Chairman from July 2014). Mr Panaccio is also Executive Chairman of Health Networks Australia, non-executive Chairman of the Inner East Community Health Service in Victoria and a non-executive director of Yarra Community Housing Limited. Mr Panaccio was the Chief Executive Officer and an executive director of Melbourne Pathology for ten years to 2001. Mr Panaccio is Chairman of the Audit Committee, a member of the Remuneration and Nomination Committee, and a member of the Risk Management Committee.

K Spargo 2  

Kate Spargo
L.L.B. (Hons), B.A., F.A.I.C.D.
Non-executive, independent Director, appointed July 2010

Ms Spargo has gained broad business experience as both a legal advisor, having worked in private practice and government, and as a director. Ms Spargo has been a director of both listed and unlisted companies over the last sixteen years and her current directorships include the ASX listed companies Fletcher Building Limited (from March 2012), UGL Limited (Non-executive Chairman from October 2014, Non-executive Director from October 2010), Adairs Limited (Non-executive Director from May 2015) and Sigma Pharmaceuticals Limited (Non-executive Director from December 2015). She is also a director of SMEC Limited, an engineering company with operations in around 40 countries, CoInvest Limited and Geelong Football Club Limited. She is a member of the International Ethics Standards Board for Accountants. Ms Spargo is Chair of the Remuneration and Nomination Committee and is a member of the Audit Committee.

Jane Wilson    

Dr Jane Wilson
M.B.B.S., M.B.A., F.A.I.C.D.
Non-executive, independent Director, appointed July 2010

Dr Wilson is an independent non-executive director with a background in finance, banking and medicine. She is a Fellow of the Australian Institute of Company Directors (AICD) and was the Queensland President and National Board Director of AICD from 2002 to 2004. Dr Wilson is currently a board member of Future Fund, Finance director of The Winston Churchill Memorial Trust, Deputy Chancellor of the University of Queensland, a member of the University of Queensland Faculty of Health Sciences Board, a director of Opal Aged Care and a director of the General Sir John Monash Foundation. Dr Wilson was appointed to the Prime Minister’s Business Advisory Council (12 Member council) in December 2013 and is a Member of the Institute for Molecular Bioscience Advisory Board and the Qld Arts Investment Advisory Board. Dr Wilson’s previous directorships include inaugural Chairman of Horticulture Australia, Chairman of IMBcom Ltd, Universal Biosensors Ltd, Energex Ltd, Sun Retail Ltd, WorkCover Qld, and other smaller biotechnology companies. She served on the Premier’s Smart State Council in Queensland and was a member of the Biotechnology Task Force. Dr Wilson is also on the boards of a number of cultural and charitable institutions. She was named in the inaugural 2012 AFR/Westpac Top 100 Women Awards in the Board/Management category. She has a Masters degree in Business Administration from the Harvard Business School and a medical degree from the University of Queensland. Dr Wilson is Chairman of the Risk Management Committee and is a member of the Remuneration and Nomination Committee.